Signaturefd LLC Buys 463 Shares of Metlife Inc (NYSE:MET)

Signaturefd LLC increased its stake in shares of Metlife Inc (NYSE:MET) by 7.8% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,413 shares of the financial services provider’s stock after acquiring an additional 463 shares during the quarter. Signaturefd LLC’s holdings in Metlife were worth $319,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of MET. Ronna Sue Cohen boosted its position in shares of Metlife by 4,021.5% during the first quarter. Ronna Sue Cohen now owns 2,686,512 shares of the financial services provider’s stock worth $2,687,000 after acquiring an additional 2,621,329 shares during the last quarter. MERIAN GLOBAL INVESTORS UK Ltd boosted its position in shares of Metlife by 57.5% during the first quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 3,642,132 shares of the financial services provider’s stock worth $155,045,000 after acquiring an additional 1,330,398 shares during the last quarter. AJO LP boosted its position in shares of Metlife by 15,027.5% during the first quarter. AJO LP now owns 1,106,877 shares of the financial services provider’s stock worth $47,120,000 after acquiring an additional 1,099,560 shares during the last quarter. SG Americas Securities LLC boosted its position in shares of Metlife by 135.7% during the first quarter. SG Americas Securities LLC now owns 230,540 shares of the financial services provider’s stock worth $9,814,000 after acquiring an additional 875,770 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Metlife by 7.4% during the fourth quarter. Geode Capital Management LLC now owns 12,421,536 shares of the financial services provider’s stock worth $509,344,000 after acquiring an additional 856,479 shares during the last quarter. Hedge funds and other institutional investors own 75.13% of the company’s stock.

MET has been the subject of a number of research reports. Citigroup set a $42.00 target price on shares of Metlife and gave the stock a “sell” rating in a research report on Thursday, May 23rd. Morgan Stanley upped their target price on shares of Metlife from $52.00 to $53.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 10th. ValuEngine downgraded shares of Metlife from a “hold” rating to a “sell” rating in a research note on Thursday, August 1st. Wells Fargo & Co upped their price target on shares of Metlife from $55.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, July 11th. Finally, Zacks Investment Research raised shares of Metlife from a “sell” rating to a “hold” rating and set a $51.00 price target on the stock in a research note on Friday, August 2nd. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company’s stock. Metlife currently has an average rating of “Hold” and an average price target of $50.91.

Metlife stock traded down $1.76 during mid-day trading on Wednesday, reaching $45.17. 166,511 shares of the company’s stock traded hands, compared to its average volume of 5,181,302. The stock has a market capitalization of $44.05 billion, a P/E ratio of 8.39, a price-to-earnings-growth ratio of 0.99 and a beta of 1.09. The firm’s 50 day moving average price is $49.30. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.14 and a current ratio of 0.14. Metlife Inc has a 12-month low of $37.76 and a 12-month high of $51.16.

Metlife (NYSE:MET) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.38 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.07. Metlife had a net margin of 9.28% and a return on equity of 9.75%. The company had revenue of $16.45 billion for the quarter, compared to the consensus estimate of $16.43 billion. During the same quarter in the prior year, the firm earned $1.30 earnings per share. Metlife’s revenue was down 22.4% on a year-over-year basis. As a group, sell-side analysts forecast that Metlife Inc will post 5.65 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 13th. Stockholders of record on Tuesday, August 6th will be paid a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 3.90%. The ex-dividend date of this dividend is Monday, August 5th. Metlife’s dividend payout ratio is currently 32.65%.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Featured Story: What does an equal weight rating mean?

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit